Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

HT-005 reduces skin plaque severity in cutaneous lupus erythematosus mouse model

Nov. 4, 2020

Concert initiates phase III THRIVE-AA1 study of CTP-543 for alopecia areata

Nov. 4, 2020

Azitra discovers recombinant microorganisms for treating atopic dermatitis

Nov. 3, 2020

New phase II data presented from BRAVE-AA1 trial of baricitinib in alopecia areata

Nov. 2, 2020

Amryt presents data from pivotal EASE study of Filsuvez in epidermolysis bullosa

Nov. 2, 2020

Leo Pharma presents pooled safety data from clinical trials of tralokinumab

Nov. 2, 2020

FDA clears IND for phase IIa study of OLX-10010 for hypertrophic scars

Nov. 2, 2020

Topline results from phase II AURORA trial of avacopan reported

Oct. 30, 2020

MediWound completes enrollment in phase II pediatric study of NexoBrid

Oct. 30, 2020

First patient dosed in phase II study of BBP-589

Oct. 29, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...